
ReLiver
Derived from an unlimited stem cell source, our cell therapy platform will ultimately transform the treatment of liver disease. We are initially targeting acute and acute-on-chronic liver failure, the most challenging conditions that currently rely on liver transplantation as the only line of treatment.
®
ReLiver™ has been designed to be:
-
Used as an allogeneic cell therapy
-
Implantable via minimally invasive surgery
-
Fully functional upon implantation
-
Easily removed without sequelae once the patient’s liver regenerates
-
Does not require immunosuppression
-
Can be cryopreserved for on-demand use
Pre-clinical data supports that ReLiver® :
-
Maintains metabolic function for 12 weeks
-
Restores liver function in models of acute liver failure, improving survival and treating hepatic encephalopathy
-
Is safe: cells are contained within the implant
-
Effectively evades the host immune system